Differential effect of verapamil on excitation-contraction coupling in smooth muscle and on excitation-secretion coupling in adrenergic nerve terminals.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000037:antagonists & inhibitors; D002415:Cats; D003326:Coronary Circulation / Q000187:drug effects*; D004558:Electric Stimulation; D004594:Electrophysiology; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects; D009411:Nerve Endings / Q000187:drug effects*; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology; D009541:Nictitating Membrane / Q000187:drug effects / Q000502:physiology; D009638:Norepinephrine / Q000097:blood / Q000494:pharmacology; D010477:Perfusion; D011189:Potassium Chloride / Q000494:pharmacology; D011651:Pulmonary Artery / Q000187:drug effects / Q000502:physiology; D011817:Rabbits; D011941:Receptors, Adrenergic / Q000187:drug effects; D013268:Stimulation, Chemical; D014700:Verapamil / Q000494:pharmacology*
D009467:Neuromuscular Depolarizing Agents; D011941:Receptors, Adrenergic; D011189:Potassium Chloride; D014700:Verapamil; D000109:Acetylcholine; D002118:Calcium; D009638:Norepinephrine